Iron supplement in Pregnant wome
Phase 4
Completed
- Conditions
- Health Condition 1: D508- Other iron deficiency anemias
- Registration Number
- CTRI/2019/09/021380
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 84
Inclusion Criteria
1. Pregnant women between 18 to 40 years of age with more than 14 weeks of gestation and
2. Serum Haemoglobin levels between 9 - 11gm/dl for oral iron supplement and <9gm/dl for parenteral iron therapy
Exclusion Criteria
1.Pregnant women of less than 14 weeks of gestation.
2. Pregnant women with complications like bleeding piles, excessive emesis, active peptic ulcer, diabetes, hypertension, eclampsia, hypothyroidism and hyperthyroidism and multiple pregnancy.
3. Pregnant women not willing to sign written informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the Mean change in the haemoglobin levels from baseline upto 60th day of different iron supplementation in antenatal mothers with iron deficiency anaemia. <br/ ><br>To assess the cost effectiveness ratio of different iron preparations prescribed. <br/ ><br>Timepoint: Day 0 and Day 60
- Secondary Outcome Measures
Name Time Method To compare the cost effectiveness of oral and parenteral iron supplements. <br/ ><br>To assess the tolerability of different iron supplements. <br/ ><br>Timepoint: Day 0 and day 60